Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
04/2005
04/13/2005CN1606456A Restricted expression lentiviral vectors
04/13/2005CN1605346A Vacuum-electrolysis and flocculation reclaiming technology for preparing
04/13/2005CN1196787C Virulence genes and proteins and their use
04/13/2005CN1196495C Mutant human CD80 and compositions and methods of making and using the same
04/13/2005CN1196492C Medicine for treating stomach disease
04/13/2005CN1196491C Ointment for healing trauumatic injury
04/13/2005CN1196472C Bacterial Chinese medical preparation and preparing method thereof
04/12/2005US6878817 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
04/12/2005US6878544 Retinal cell lines with extended life-span and their applications
04/12/2005US6878543 Cultures of GFAP+ nestin+ cells that differentiate to neurons
04/12/2005US6878541 Papilloma pseudo-virus and preparation
04/12/2005US6878383 Compositions for regenerating tissue that has deteriorated, and methods for using such compositions
04/12/2005US6878377 Mycobacterium vaccae for down-regulation of the Th2 activity of the immune system
04/12/2005US6878375 HA-1 antigen
04/12/2005US6878373 Probiotic composition containing Bacillus cereus RRRL B-30535
04/12/2005US6878371 Isolating autologous bone marrow- mononuclear cells from the subject; and transplanting locally into the tissue an effective amount of the autologous bone-marrow mononuclear cells, resulting in formation of new blood vessels in tissue
04/12/2005US6877514 Organ transplantation; administering a relatively large number of stem cells, combined with the creation of thymic space without the need for whole body irradiation; mixed chimerism can be formed without hematopoietic space-creating irradiation
04/12/2005CA2385854C Formulation for menopausal women
04/12/2005CA2208051C Systems and method for removing free and entrained contaminants in plasma
04/07/2005WO2005030939A2 Method and composition for regulating expansion of stem cells
04/07/2005WO2005030251A1 Compositions and methods to accelerate hematologic recovery
04/07/2005WO2005030230A1 Compositions and methods for treatment or prevention of psoriasis and related disorders
04/07/2005WO2005030229A1 Probiotic storage and delivery
04/07/2005WO2005030190A1 Natural menaquinone 7 compositions
04/07/2005WO2005030139A2 Seneca valley virus based compositions and methods for treating disease
04/07/2005WO2005030122A2 Inactivated host cell delivery of polynucleotides encoding immunogens
04/07/2005WO2005003334A3 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
04/07/2005WO2005000034A3 Lactic bacteria and its use in direct-fed microbials
04/07/2005WO2004099394A3 A method for efficient transfer of human blastocyst-derived stem cells (hbs cells) from a feeder-supported to a feeder-free culture system
04/07/2005WO2004066953A3 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing
04/07/2005WO2004066947A3 Hyperthermia oncolysis co-therapy
04/07/2005WO2004023100A3 Cd56 positive human adult pancreatic endocrine progenitor cells
04/07/2005WO2004010959A3 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith
04/07/2005WO2004007695A3 Lactobacilli expressing biologically active polypeptides and uses thereof
04/07/2005US20050076396 Adipocyte progenitor cell for use as tool in bone marrow harvesting; tissue engineering and regenerative medicine
04/07/2005US20050075305 Therapeutic compositions and methods of treating glycolipid storage related disorders
04/07/2005US20050075298 Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa
04/07/2005US20050075268 cell is contacted with a photosentistising agent, cell is irradiated with light to activate photosentisitising agent, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination
04/07/2005US20050075102 Personal-call and feature control system and method for controlling telephones, providing extended features for such telephones and routing of media-rich calls
04/07/2005US20050074882 Using immunoglobulin specific to human leukocyte antigen receptor to modify mitochondrial metabolism and kill tumor cells; immunotherapy; antitumor agents
04/07/2005US20050074880 Generation of multipotent central nervous system stem cells
04/07/2005US20050074876 Cultured, immortalized, non-transformed mammalian hepatic cell line for use as tool in treatment of disease; tissue engineering and regenerative medicine
04/07/2005US20050074849 Peptides
04/07/2005US20050074742 Engineered bone tissues propagating on growth matrix; tissue engineering and regenerative medicine
04/07/2005US20050074505 Reduced heat of hydration in wound area; adjusted calcium content; one step treatment; rapid clotting; minimizing discomfort
04/07/2005US20050074481 Device for regeneration of articular cartilage and other tissue
04/07/2005US20050074477 Method for the treatment of diseased, degenerated, or damaged tissue using three dimensional tissue produced in vitro in combination with tissue cells and/or exogenic factors
04/07/2005US20050074461 Transdermal botulinum toxin compositions
04/07/2005US20050074442 Compositions and methods for augmenting kidney function
04/07/2005US20050074441 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome
04/07/2005US20050074440 Lactobacillus rhamnosus strain and uses thereof
04/07/2005US20050074439 Utilized for expression of desired heterologous DNAs
04/07/2005US20050074436 Systems and methods for treating patients with processed lipoaspirate cells
04/07/2005US20050074435 Enriching stem and progenitor cells by positive or negative selection of hematopoietic cells from umbilical cord blood; culturing under proliferation conditions that increase differentiation potential
04/07/2005US20050074427 IL-17 like molecules and uses thereof
04/07/2005US20050074423 subtilisin, pepsin or trypsin used for the protein hydrolysis of ground oyster flesh; liquid form; freeze dried powder form
04/07/2005US20050074416 lactic bacteria strain dairy in origin, may administer in an edible composition, adheres to tooth surface and produces growth inhibition factor
04/07/2005CA2540177A1 Seneca valley virus based compositions and methods for treating disease
04/07/2005CA2539974A1 Methods of using ammonia oxidizing bacteria
04/07/2005CA2539947A1 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage
04/07/2005CA2539716A1 Compositions and methods to accelerate hematologic recovery
04/07/2005CA2538676A1 Probiotic storage and delivery
04/07/2005CA2537890A1 Fermentation and culture method using pantoea agglomerans, and fermentedwheat extract and composition containing the fermented wheat extract
04/07/2005CA2537335A1 Use of antisecretory factor for neuroprotection
04/06/2005EP1520583A2 NKT cell-activating agents containing alpha-glycosylceramides
04/06/2005EP1520175A2 Oncolytic viruses as phenotyping agents for neoplasms
04/06/2005EP1520015A2 Plant deoxyribonucleoside kinase enzymes and their use
04/06/2005EP1520009A2 Method for preparing animal or human adult stem cells and therapeutic use thereof
04/06/2005EP1519755A2 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
04/06/2005EP1519736A2 Use of hec1 antagonists in the treatment of proliferative disorders and cancer
04/06/2005EP1490475A4 Muscle cells and their use in cardiac repair
04/06/2005EP1218494B1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
04/06/2005EP1214084B1 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems
04/06/2005EP0824594B1 Improved methods for transfecting t cells
04/06/2005EP0553244B2 Targeted immunostimulation with bispecific reagents
04/06/2005CN1604962A Cell constructs cultured in vitro, preparation and uses
04/06/2005CN1604777A Method of treatment
04/06/2005CN1602894A Health protecting product composition with liver protecting and blood fat regulating function and its preparation
04/06/2005CN1602893A Pharmaceutical composition for treating cerebral apoplexy and its preparation method
04/06/2005CN1602739A Ostrich glue and its preparation method
04/06/2005CN1602707A Ferreous solid drink and its production process
04/06/2005CN1195864C Slowviral vector
04/06/2005CN1195860C Delivery of biologically active polypeptides
04/06/2005CN1195769C Natural antitumor or antiviral substances and use of the same
04/06/2005CN1195546C Application of monoclone antibody combined with CD154 for inhibiting rejection of insulin generating transplanted tissue
04/06/2005CN1195538C Capsule for treating rheumatalgia
04/06/2005CN1195533C Medicine for treating cholelithiasis
04/06/2005CN1195532C Oral capsule for treating condyloma acuminata
04/06/2005CN1195530C Lactic acid bacteria strains capable of preventing diarrhea
04/06/2005CN1195529C Composition containing muscle-derived active agents
04/06/2005CN1195528C Pilose antler composition and method for preparing the same
04/06/2005CN1195514C Metabolites of ecteinascidin 743
04/05/2005US6875845 Polypeptide for use in the treatment of cancer
04/05/2005US6875844 Recombinant or chemically synthesized intestinal carboxyesterase (ICE)amino acid sequences for treating solid tumors
04/05/2005US6875612 Expression vector coding proteins for use in the treatment of tumors
04/05/2005US6875607 Embryonic stem cells
04/05/2005US6875430 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
04/05/2005US6875191 Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leukofilter
04/05/2005CA2161798C Animal model for hepatitis virus infection
04/03/2005CA2444292A1 Bipotential liver cell lines from wild-type mammalian liver tissue